Auranofin PK Following Oral Dose Administration

NCT02089048 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

NIH

Sponsor class

Conditions

Amoebiasis

Interventions

DRUG: Auranofin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)